United States · FDA National Drug Code directory
Pomalidomide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-039_d7629b96-2ace-4a2e-a70c-e73d41a990f9
- Product NDC
- 69097-039
- Form
- CAPSULE
- Composition / generic term
- Pomalidomide
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260830
- Source listing expiry
- 20271231
Source-listed ingredients
- POMALIDOMIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (69097-039-07) · 69097-039-07
- 21 CAPSULE in 1 BOTTLE (69097-039-81) · 69097-039-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →